Hearings
Subcommittee on Terrorism, Nonproliferation and Trade
Brad Sherman (D-CA), Chairman
Genetics and other Human Modification Technologies:
Sensible International Regulation or a New Kind of Arms Race?
Transcript [PDF]
Thursday, June 19, 2008
Room 2200 of the Rayburn House Office Building
Paul R. Billings M.D., Ph.D.
President and Chief Executive Officer
Cellpoint Diagnostics, Inc.
Jamie F. Metzl, Ph.D
Executive Vice President
Asia Society
Nigel M. de S. Cameron, Ph.D.
President and Co-founder
Institute on Biotechnology and the Human Future
Richard Hayes, Ph.D.
Executive Director
Center for Genetics and Society